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BRIEF REPORT
A microcosting study of the surgical correction of upper extremity deformity in
children with spastic cerebral palsy
Juul Vera Alewijnsea, Ellen M. van Rooijenb, Mick Kreulena, Mark JC Smeuldersa, and Siok Swan Tanb
aDepartment of Plastic, Reconstructive and Hand Surgery, Academic Medical Center, Amsterdam, The Netherlands; bInstitute for Medical
Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
ABSTRACT
Objective: Determine healthcare costs of upper-extremity surgical correction in children with spastic
cerebral palsy (CP). Method: This cohort study included 39 children with spastic CP who had surgery for
their upper extremity at a Dutch hospital. A retrospective cost analysis was performed including both
hospital and rehabilitation costs. Hospital costs were determined using microcosting methodology.
Rehabilitation costs were estimated using reference prices. Results: Hospital costs averaged €6813 per
child. Labor (50%), overheads (29%), and medical aids (15%) were important cost drivers. Rehabilitation
costs were estimated at €3599 per child. Conclusions: Surgery of the upper extremity is an important
contributor to the healthcare costs of children with CP. Our study shows that labor is the most important
cost driver for hospital costs, owing to the multidisciplinary approach and patient-specific treatment
plan. A remarkable finding was the substantial amount of rehabilitation costs.
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Introduction
Cerebral palsy (CP) is a non-progressive central nervous
system disorder of motor function that is caused by damage
to the brain in the fetal or perinatal period. In the last decade
of the twentieth century, the prevalence of CP in very low
birth weight infants substantially increased. The prevalence of
CP in juveniles has risen to about 2.5 per 1000 life births in
the 1990s in northwestern Europe.1 This seems to be attribu-
table to the increased survival of newborns resulting from
improved neonatal intensive care.2
The most common form of CP is spastic CP, 72%–91% of
those with CP, in which children have an imbalance between
spastic and paretic muscles.1,3 Spasticity of flexion and adduc-
tion muscles and weakness of extension and abduction mus-
cles often cause upper limb deformities in children with
spastic CP. These deformities will significantly affect motor
function, resulting in difficulties with reaching, pointing,
grasping, releasing, and manipulating objects.4
Interventions for improving upper limb function in chil-
dren with CP include physiotherapy, occupational therapy,
peripheral casting, the use of botulinum toxin, and surgery.
Surgery consists of releasing or lengthening the spastic or
contracted muscles, augmenting the weak or flaccid muscles
through tendon transfers and stabilizing the joints as needed.
All procedures are typically performed in one surgical session.
Although surgery cannot fully eliminate the deformity, it can
produce substantial improvements in upper limb function.5
Improvement can be realized for children who are selected
carefully through complete physical examination, motor and
sensory function assessment, and clinical evaluation of
impairment of daily life activities.6 By international
convention, this selection is done by a multidisciplinary
team consisting of at least a hand surgeon, occupational
therapist, and rehabilitation specialist. This multidisciplinary
team tailors each surgery to a patient’s individual problems
and needs.7
Healthcare costs of children with CP are 1.8 times higher
than those of a child without CP in the USA.8 The average
lifetime healthcare costs of patients with CP are reported to be
€860 000 for men and €800 000 for women in Denmark.9
Treatments for children with the spastic type show the highest
costs, due to the fact that surgical procedures are frequent in
these children.10 Of these surgeries, Murphy et al.8 showed that
soft-tissue musculoskeletal procedures are the second most
frequently performed, after gastrostomy tube insertions, and
accounted for US$ 11 445 (EURO 2014: €11 540, converted
with purchasing power parity (PPP)11) per patient.
Costing studies are a prerequisite for registration, reim-
bursement, and pricing of hospital services in many coun-
tries, because they can provide healthcare decision-makers
with valuable information on the relative efficiency of
different services.12 For costing studies, the microcosting
approach is seen as the gold standard method, because it
allows for the identification of costs per individual patient
and for insight into patient subgroups that might have a
great share in the total costs. As this methodology is time
consuming, it has not been widely used in assessing costs
in the CP population.13
The aim of this study is to calculate healthcare costs of the
surgical correction of upper-extremity deformity in children
with spastic CP using the microcosting approach. Health care
costs will include both hospital and rehabilitation costs.
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Method
This microcosting study was performed in conjunction with a
clinical trial. More details of the study design can be read in
the clinical results paper published in 2015.14 In short, all
children with spastic CP who had surgery for their upper
extremity between April 2003 and April 2008 at the
Academic Medical Center (AMC) in Amsterdam were
included. When complete data on resource use were not
available from the hospital information system, the patient
was excluded. Given the retrospective nature of this cost
analysis and the absence of direct patient contact, no approval
of the research ethics committee was necessary.
This retrospective cost analysis is performed from a health-
care provider’s perspective, including hospital and costs of the
rehabilitation program after the intervention. All costs are
based on Euro 2014 cost data. Where necessary, costs were
adjusted to 2014 using the general price index from the Dutch
Central Bureau of Statistics.15
Hospital costs
Hospital costs consisted of medical costs from the first contact
with the hospital, related to the surgery in question, until the
last checkup, 9 months after surgery. These costs also include
visits to the hospital after admission, such as checkups (assess-
ment of motor function, changing casts, and receiving splints)
and medical aids. The microcosting methodology is used to
calculate all hospital costs, in which all relevant cost compo-
nents are identified at the most detailed level.13 Bottom-up
microcosting was used to calculate hospital costs. This meth-
odology is characterized by the identification of patient-spe-
cific resource use and hospital-specific unit costs.13,16 When
hindered by the incompleteness of hospital databases, top-
down microcosting was accepted, which uses resource use
for an average patient and unit costs derived from standard
or estimated costs.13
Healthcare resource use was identified per individual
patient from the patient’s file in the hospital information
system. This provided an insight into patient specific infor-
mation, e.g., number of hospital days, type of anesthetic,
materials and devices used, complications after surgery, and
actions taken as result of these complications. After collecting
this data, more details were needed regarding hours of labor,
hours in certain rooms to calculated overheads, medical aids
and medication received, and devices and materials used
during surgery and checkups. This was collected through
interviews containing open-ended questions with a hand sur-
geon, a resident in training for hand surgery, and an occupa-
tional therapist. Manufacturers were used as an alternative
source of information on durability of equipment and
materials.
The following unit costs were collected from the hospi-
tal database: admission costs and costs on the ward (inpa-
tient stay), labor (e.g., physicians, nurses, OR nurses,
administrative staff), anesthetics, devices, and materials.
As approximately 80% of the children stayed at the
“Teenagers”-ward and 20% at the “Older Children”-ward,
costs of admission and inpatient stay are a weighted
average of the costs at these two different wards. Unit
costs of labor were expressed in costs per minute, calcu-
lated by dividing the normative income by the number of
workable minutes a year. Normative incomes were based
on collective labor agreements. When not available from
hospital databases, unit costs of devices and materials were
gathered from the manufacturers. Medication costs and
costs of additional diagnostics performed due to compli-
cations were calculated with the use of wholesale prices.-
17,18 Unit costs of medical aids were collected through
interviews with an occupational therapist, orthopedic tech-
nician, and manufacturers. The overheads were gathered
through an interview with an employee of the housing
division and translated in hourly rates for the use of
different types of rooms in the hospital. These overheads
included costs due to general expenses, administration and
registration, power usage, maintenance, insurance, and
personnel costs of non-patient services, e.g., management,
depreciation of buildings or inventory, and interest.
Bottom-up microcosting could be performed for the calcu-
lation of hospital costs concerning admission, inpatient stay,
materials used, anesthetics given, and some of the devices
used. Top-down microcosting methodology was used calcu-
lating overheads, labor, medication, medical aids, complica-
tions, and some other devices used.
Rehabilitation costs
The rehabilitation program consists of occupational and phy-
siotherapy. Information on resource use during a rehabilita-
tion of average duration for this type of children was collected
through an interview with a rehabilitation specialist. Standard
costs for rehabilitation were taken from the cost manual.19
With this information, rehabilitation costs after the surgical
correction of upper-extremity deformity in children with
spastic CP were estimated.
Sensitivity analysis
To determine the uncertainty of the obtained cost estimates,
one-way sensitivity analyses were carried out by individually
varying each unit cost value between 50% and 150%. This
range is in agreement to earlier microcosting studies con-
ducted in many other study populations (among
others:15,20,21).
Results and discussion
Forty children were eligible for this study. One child was
excluded due to incomplete resource use documentation;
therefore 39 children were included in this study. Table 1
shows the patient characteristics at the time of surgery.
An overview of the unit costs is provided in Table 2. The
mean total hospital costs for the correction of the upper
extremity in children with spastic CP are €6813. Labor
accounted for 50%, which may be explained by the multi-
disciplinary approach and patient-specific treatment plan.
Overhead costs accounted for 29%, medical aids for 15%,
and materials and devices for 6% of the total hospital costs.
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According to the hospital information system, the children
stay approximately 3.5 days at the ward during hospitaliza-
tion. Costs for this inpatient stay are €2773. This includes
overheads, labor, equipment, and material and medication
costs directly related to the ward. The children are in the
operation room for 3.5 h, of which the surgery takes 2.5 h.
Before and after surgery, the children spend 2 h on the
recovery ward and all operations were performed under gen-
eral anesthesia. Total costs for surgery were €1345, including
labor, anesthetics, material, devices, and overhead costs
directly related to surgery and recovery stay. Some developed
minor complications or required additional diagnostics,
which can be found in Table 2. Also after admission, 10% of
the children needed a new scotch cast, which accounts for an
additional €20 per child. During admission, resource use of
the children was consistent, which accounts for little variabil-
ity in hospital costs between the children. This may be due to
short hospitalization, a small age distribution, few complica-
tions, and because all operations were performed by the same
hand surgeon (MK).
Six weeks after surgery, a rehabilitation program at a
rehabilitation center close to the child’s residence was started.
All of the children received physiotherapy 2.5 times a week
(personal interview with rehabilitation specialist BI, August
2013; unreferenced). Seventy percent of the children received
additional occupational therapy 2.5 times a week. Each treat-
ment, physiotherapy or occupational therapy, took 30 min.
On average, the total duration of the rehabilitation program
was 3.5 months. Standard costs for rehabilitation (physiother-
apy or occupational therapy) are €121 per hour,19 which gives
a total cost estimation of €3599 for the rehabilitation process
per child. As these rehabilitation costs were roughly esti-
mated, no conclusions can be drawn with regard to aspects
that could have influenced these costs, e.g., cognition or the
degree of spasticity of the children.
A sensitivity analysis is shown in Table 3. Total costs
changed 16% when labor costs and 9% when overhead costs
were varied by 50%. The influence of varying the remaining
cost components also appeared to be rather modest, namely
between 2% and 5% (hospital costs: 3%–7%).
In the Netherlands, the price in 2008 for the Dutch
Diagnosis Related Group (DRG)-like DBC-tariff (“Diagnose-
Behandel-Combinatie” translated as “diagnosis-treatment-
combination”) matching this surgery was €517718 (EURO
2014: €5762). A DBC can be defined as a predefined average
care package with a fixed price for a specific diagnosis and
treatment. Payments received by the hospital from insurance
companies are based on these DBCs. This difference suggests
there was a discrepancy between costs made by hospitals and
payment received from insurance companies in 2008. Also the
reference price of inpatient stay at an academic hospital was
lower compared to our daily costs of inpatient stay—€53919
versus €792. This difference may be attributed to a difference
in hospital care between adults and children, and the costs of
inpatient stay may be higher when patients had surgery com-
pared to a hospitalization without surgery. However, Murphy
et al.22 showed average costs of US$ 15 478 (EURO 2014: €15
606, converted with PPP11) per hospitalization related to
musculoskeletal and connective tissue system disorders in
the US (resource use collection was done in 1997), which is
more than twice calculated hospital costs in this article. This
may be due to the inclusion of more costly operations, e.g.,
operations on the lower extremities, spine, and hip.
Additionally, what contributed to our relatively low hospital
costs was the performance of all surgeries by the same
experienced hand surgeon, which lowers operation time and
therefore the total costs of surgery, the absence of serious
postoperative complications and the short duration of hospi-
talization. This meets the findings of another study of Murphy
et al.,8 in which low rates of complications and relatively brief
hospitalizations in musculoskeletal surgeries of the hips and
extremities in patients with CP were reported. In our hospital,
children are operated on the second day of admission. One
day on the ward costs €792 in our study. However, the AMC
has extensive clinical experience with the current surgery and
postoperative regime, given the high costs of inpatient stay; it
would be interesting to know if shorter admission or post-
operative therapy will lead to poorer results.
Putting the results in perspective, it is important to know
the clinical results of this surgery14 Clinical improved position
of the thumb, 5–11 years after surgery, was present in 80% of
the patients. Combined with the costs calculated by this study,
the costs per clinical improved thumb position after surgery
could be estimated at €13 015. In the article, we stated that to
optimize the success rate, careful assessment, selection, and
planning before surgery is required.14 This approach may
account for less complications and less failures, which will
optimize the cost-effectiveness.
Unfortunately, a reliable cost-effectiveness or -utility ana-
lysis could not be performed. A clinical outcome measure
(except for thumb position) was not available, and analyzing
this did not fit the scope of this article. Also a generally
accepted outcome measure for utility to perform a cost-utility
analysis, like quality-adjusted life years (QALY), was not
available for this population. It is difficult to isolate QALY
directly related to upper-extremity function, as children with
CP are often coping with more than one disorder related to
their illness. This broad spectrum of disorders in CP also
makes it difficult to perform a study from a broader societal
point of view, due to difficulties in isolating costs made and
gains received by the parents directly related to the surgery.
For example, out-of-pocket costs from the parents could have
been collected from interviews with the parents. However,
recall bias would have had a major influence on the answers
given the time frame.
Ruiz et al.23 showed that the use of botulinum toxin in the
management of children with CP led to a significant reduction in
requirement for surgery compared to their control group. This led
to a reduction in the costs of managing a child with CP. However,
the studied period was only 1 year and botulinum toxin is a short-
Table 1. Patient characteristics at baseline.
n 39
Age 12.38 (SD 3.7)
Sex
Male 64%
Female 36%
5–10 year success rate of surgery 80%
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Table 2. Resource use and unit costs (Euro 2014), n = 39.
Resource
use
Unit
costs
Costs per
patient Information source volume Cost price
HOSPITAL COSTS
Diagnostics by multidisciplinary team
Labor (in min)
Hand surgeon 45 1.69 76.19 Hand surgeon Hospital database
Resident hand surgery 45 0.56 25.26 Hand surgeon Hospital database
Rehabilitation specialist 45 1.64 73.60 Hand surgeon Hospital database
Occupational therapist 110 0.55 60.07 Occupational therapist Hospital database
Overheads (in minutes)
Outpatient clinic by multidisciplinary team 45 0.08 3.79 Hand surgeon Division Housing
Outpatient clinic by occupational therapist 45 0.08 3.79 Occupational therapist Division Housing
Total costs of diagnostics by multidisciplinary team 242.69 (SD 33.70)
Consult anesthesiology
Labor (in min)
Anesthesist 20 1.61 32.20 Hospital database Hospital database
Overheads (in min)
Outpatient clinic anesthesiology 20 0.08 1.68 Hospital database Division Housing
Total costs of consult anesthesiology 33.89 (SD 21.59)
Hospitalization
Admission
Labor medical specialists 1 234.07 234.07 Hospital database Hospital database
Labor other personnel 1 246.73 246.73 Hospital database Hospital database
Materials 1 59.47 59.47 Hospital database Hospital database
Overheads 1 391.66 391.66 Hospital database Hospital database
Inpatient stay (in days)
Labor medical specialists 3.5 113.85 398.47 Hospital database Hospital database
Labor other personnel 3.5 287.37 1005.81 Hospital database Hospital database
Materials 3.5 31.87 111.55 Hospital database Hospital database
Overheads 3.5 359.05 1256.67 Hospital database Hospital database
Medication
Paracetamol 4 0.13 0.53 Resident hand surgery Medicijnkosten.nl
Oxycontin 2 0.17 0.34 Resident hand surgery Medicijnkosten.nl
Oxinorm 6 0.10 0.61 Resident hand surgery Medicijnkosten.nl
Medical aids
Scotchcast 1 151.50 151.50 Hand surgeon Orthopedic technician
Removable splint 1 252.50 252.50 Hand surgeon Orthopedic technician
Night splint 1 555.50 555.50 Hand surgeon Manufacturer
Inter physician communication
Labor (in min)
Hand surgeon 25 1.69 42.33 Hand surgeon Hospital database
Rehabilitation specialist 10 1.69 16.93 Hand surgeon Hospital database
Complications
Lab application 17/39 14.12 6.16 Hospital database Nederlandse
Zorgautoriteit
Electrocardiography 1/39 22.35 0.57 Hospital database Nederlandse
Zorgautoriteit
Ultrasound arm 2/39 82.49 4.23 Hospital database Nederlandse
Zorgautoriteit
Histological research 1/39 59.26 1.52 Hospital database Nederlandse
Zorgautoriteit
Ultrasound bladder 8/39 82.49 16.92 Hospital database Nederlandse
Zorgautoriteit
Scotchcast 1/39 372.69 9.56 Hospital database Orthopedic technician
Scotchcast 1/39 559.04 14.33 Hospital database Orthopedic technician
Total costs of hospitalization 4777.96 (SD 333.04)
Surgery
Labor (in min)
Hand surgeon 150 1.69 253.97 Hand surgeon Hospital database
Resident hand surgery 180 0.56 101.05 Hand surgeon Hospital database
OR assistant 420 0.57 238.28 Hand surgeon Hospital database
Anesthesist 105 1.61 169.06 Hand surgeon Hospital database
Resident anesthesiology 210 0.56 116.86 Hand surgeon Hospital database
Surgery materials 201.03 Surgery center Surgery center
General anesthesia 39.90 Hospital database Anesthesist
Devices (in minutes)
OR 210 0.03 7.14 Division Housing Division Housing
Recovery 120 0.01 0.83 Division Housing Division Housing
Overheads (in minutes)
OR 210 0.84 176.75 Hand surgeon Division Housing
Recovery 120 0.34 40.40 Hand surgeon Division Housing
Total costs of surgery 1345.26 (SD 91.73)
New scotschcast after admission (in 10% of the children)
Labor (in minutes)
Orthopedic technician 45 0.58 2.59 Hand surgeon Hospital database
Overheads (in min)
Plaster room 45 0.51 2.27 Hand surgeon Division Housing
Scotchcast 151.50 15.15 Hand surgeon Orthopedic technician
Total costs of new scotchcast after admission 20.01 (SD 7.35)
(Continued )
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term solution. Since surgery ensures a long-term clinical improve-
ment of position,14 surgery may be more cost-effective in the long
term. Also performing a valid study comparing botulinum toxin
and surgery would be difficult, as treatment selection strongly
depends on the severity of the spasticity. Also no other treatments
equivalent to surgery are available. Therefore, it was not possible
to add a control group to our population.
Since CP is a disease with a wide range of clinical features,
Park et al.10 stated that healthcare cost should be considered
in light of the physiological types and extent of involvement.
Our study population is as homogenous as possible. Patients
included had the same type of spasticity, similar extent of
gross motor function, same aim of surgery, and no traumatic
injuries to or prior surgical intervention on the operated arm.
Such a specific patient group and the infrequent execution of
this surgery results in a small study population, which is a
limitation. The multidisciplinary team of the AMC in
Amsterdam performs almost half of all the upper-extremity
surgeries in children with CP in the Netherlands. This is the
reason the study was performed in only one hospital, and
interviews were held only with one person per profession.
Because of the infrequent performance of the surgery, the
study population was included from April 2003 until April
2008. However, as the results are presented as transparently as
possible (Table 2), researchers may adjust estimations of
resource use and unit costs to their own specific setting
when desired. Moreover, the sensitivity analysis demonstrated
the robustness of the results. Although this study was con-
ducted in a single Dutch hospital, we thus believe that our
findings could be representative of other hospitals and other
countries, especially those in which the general practitioner
operates as the gatekeeper of specialist health care.
Table 2. (Continued).
Resource
use
Unit
costs
Costs per
patient Information source volume Cost price
Checkup by multidisciplinary team
Labor (in minutes)
Hand surgeon 30 1.69 50.79 Hand surgeon Hospital database
Resident hand surgery 30 0.56 16.84 Hand surgeon Hospital database
Rehabilitation specialist 30 1.69 50.79 Hand surgeon Hospital database
Occupational therapist 110 0.55 60.07 Occupational therapist Hospital database
Overheads (in minutes)
Outpatient clinic by multidisciplinary team 30 0.08 2.53 Hand surgeon Division Housing
Outpatient clinic by occupational therapist 45 0.08 3.79 Occupational therapist Division Housing
Devices (corrected for durability)
AHA test / 5208 510.05 0.10 Occupational therapist and
manufacturer
Occupational therapist
Box & Block test / 5208 285.97 0.05 Occupational therapist and
manufacturer
Occupational therapist
Goniometer / 1562 45.45 0.03 Occupational therapist and
manufacturer
Occupational therapist
Handheld dynamometer / 5208 338.35 0.06 Occupational therapist and
manufacturer
Occupational therapist
Pinchmeter / 5208 292.90 0.06 Occupational therapist and
manufacturer
Occupational therapist
Total costs of checkup by multidisciplinary team 185.11 (SD 24.41)
Other checkups
Labor (in min)
Hand surgeon 30 1.69 50.79 Hand surgeon Hospital database
Orthopedic technician 120 0.58 69.01 Hand surgeon Hospital database
Rehabilitation specialist 15 1.69 25.40 Hand surgeon Hospital database
Overheads (in min)
Plaster room 120 0.51 60.60 Hand surgeon Division Housing
Outpatient clinic by hand surgeon and rehabilitation
specialist
30 0.08 2.53 Hand surgeon Division Housing
Total costs of other checkups 208.33 (SD 27.32)
TOTAL HOSPITAL COSTS 6813.24 (SD 222.03)
Total costs of labor 3417.16 (SD 209.44)
Total costs of overheads 1946.45 (SD 363.51)
Total costs of medical aids 998.54 (SD 214.31)
Total costs of materials and devices 409.72 (SD 57.07)
REHABILITATION COSTS
Physiotherapy (in h) 17.5 120.96 2116.82 Rehabilitation specialist Standard prices
Occupational therapy (in 70% of the children) 17.5 120.96 1481.78 Rehabilitation specialist Standard prices
TOTAL COSTS OF REHABILITATION 3598.60 (SD 449.05)
Table 3. Sensitivity analysis.
Variation unit cost value % change in total costs when unit cost
value varied by 50%
% change in hospital costs when unit cost
value varied by 50%50% 150%
Labor 1708.58 5125.74 16.41 25.08
Overheads 973.23 2919.68 9.35 14.28
Medical aids 499.27 1497.81 4.80 7.33
Materials and devices 204.86 614.58 1.97 3.01
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This article is the first that describes the costs of the surgical
correction of upper limb deformity in children with spastic CP.
We conclude that hospital costs for this surgery are the most
important contributor to the healthcare costs of a child with CP
(€6813). Labor accounts for the highest cost; therefore to reduce
costs, effective use of hospital staff is important. Furthermore,
rehabilitation costs after this surgery are substantial (€3599). This
emphasizes the importance of taking follow-up costs into account
when calculating costs of a musculoskeletal surgical intervention.
Our study has demonstrated the importance of evaluating
health care costs of children with CP, which are higher than
average.8–10,22 To gain more insight into the total health care
costs of children with CP, further research is needed on costs
of other treatments for children with, also other types of, CP.
Furthermore, it is desired to weight costs against clinical
parameters, providing hospital managers, insurance compa-
nies, and policy makers with valuable information on the
relative efficiency of alternative options.
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